Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom
被引:0
|
作者:
A. Svedbom
论文数: 0引用数: 0
h-index: 0
机构:ICON,Centre for Metabolic Bone Diseases
A. Svedbom
P. Hadji
论文数: 0引用数: 0
h-index: 0
机构:ICON,Centre for Metabolic Bone Diseases
P. Hadji
E. Hernlund
论文数: 0引用数: 0
h-index: 0
机构:ICON,Centre for Metabolic Bone Diseases
E. Hernlund
R. Thoren
论文数: 0引用数: 0
h-index: 0
机构:ICON,Centre for Metabolic Bone Diseases
R. Thoren
E. McCloskey
论文数: 0引用数: 0
h-index: 0
机构:ICON,Centre for Metabolic Bone Diseases
E. McCloskey
R. Stad
论文数: 0引用数: 0
h-index: 0
机构:ICON,Centre for Metabolic Bone Diseases
R. Stad
B. Stollenwerk
论文数: 0引用数: 0
h-index: 0
机构:ICON,Centre for Metabolic Bone Diseases
B. Stollenwerk
机构:
[1] ICON,Centre for Metabolic Bone Diseases
[2] Frankfurt Center of Bone Disease,Centre for Integrated research in Musculoskeletal Ageing (CIMA), Mellanby Centre for Bone Research